Table 2.
Baseline characteristics of LEAOD patients between the restenosis and non-restenosis groups
| Characteristic | Restenosis group (n=79) | Non-restenosis group (n=327) | P |
|---|---|---|---|
| Male | 54 (68.35%) | 251 (76.76%) | 0.147 |
| Female | 25 (31.65%) | 76 (23.24%) | |
| BMI (kg/m2) | 23.11 ± 2.86 | 22.62 ± 2.31 | 0.108 |
| Age (year) | 62.02 ± 19.97 | 58.13 ± 9.98 | 0.014 |
| Course of disease (year) | 3.16 ± 0.63 | 3.05 ± 0.43 | 0.069 |
| Fontaine staging | |||
| II | 19 (24.05%) | 155 (47.40%) | |
| III | 45 (56.96%) | 162 (49.54%) | <0.001 |
| IV | 15 (18.99%) | 10 (3.06%) | |
| Smoking | 54 (68.35%) | 215 (65.75%) | 0.693 |
| Diabetes | 50 (63.29%) | 76 (23.24%) | <0.001 |
| Hypertension | 50 (63.29%) | 118 (36.09%) | <0.001 |
| Coronary heart disease | 15 (18.99%) | 62 (18.96%) | 1.000 |
| Myocardial infarction | 15 (18.99%) | 72 (22.02%) | 0.648 |
| Hyperlipidaemia | 14 (17.72%) | 64 (19.57%) | 0.874 |